Moxisylyte
Moxisylyte (Thymoxamine) is an alpha 1-selective antagonist with activity that improves bladder emptying. Moxisylyte is used to suppress urinary difficulties in patients with multiple system atrophy (MSA) by blocking alpha 1-adrenergic receptors to reduce the amount of residual urine after urination. Moxisylyte is also used to suppress erectile dysfunction and can improve blood circulation problems caused by Raynaud's syndrome in the short term. In addition, Moxisylyte can be applied topically to the eye to reverse the mydriasis caused by phenylephrine and other sympathetic stimulants[1].
Product Specifications
CAS Number
[54-32-0]
Product Name Alternative
Thymoxamine
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Adrenergic Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/moxisylyte.html
Smiles
CC(C1=C(OCCN(C)C)C=C(C)C(OC(C)=O)=C1)C
Molecular Formula
C16H25NO3
Molecular Weight
279.37
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P405-P501
References & Citations
[1]Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Launched
Explore Other Products
Browse additional items from our catalog
Sheep T-cell immunoglobulin and mucin domain-containing protein 4 ELISA kit
EphB6, CT (H990) (Ephrin Type-A Receptor 6, Tyrosine-protein Kinase Receptor EPH-6, HEP)
